| BioCyc:META_PWY-6377 |
α-tocopherol degradation |
| BioCyc:HUMAN_PWY-6377 |
α-tocopherol degradation |
| Reactome:R-HSA-9709957 |
Sensory Perception |
| Reactome:R-MMU-9709957 |
Sensory Perception |
| Reactome:R-RNO-9709957 |
Sensory Perception |
| Reactome:R-HSA-211859 |
Biological oxidations |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-211859 |
Biological oxidations |
| Reactome:R-MMU-2453902 |
The canonical retinoid cycle in rods (twilight vision) |
| Reactome:R-RNO-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-HSA-211976 |
Endogenous sterols |
| Reactome:R-MMU-211976 |
Endogenous sterols |
| Reactome:R-MMU-2187338 |
Visual phototransduction |
| Reactome:R-RNO-211859 |
Biological oxidations |
| Reactome:R-HSA-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-HSA-2187338 |
Visual phototransduction |
| Reactome:R-MMU-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-RNO-2187338 |
Visual phototransduction |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-HSA-2453902 |
The canonical retinoid cycle in rods (twilight vision) |
| Reactome:R-MMU-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-RNO-211976 |
Endogenous sterols |
| Reactome:R-RNO-2453902 |
The canonical retinoid cycle in rods (twilight vision) |
| PathBank:SMP0000083 |
Acetylsalicylic Acid Action Pathway |
| PathBank:SMP0000087 |
Rofecoxib Action Pathway |
| PathBank:SMP0000094 |
Sulindac Action Pathway |
| PathBank:SMP0000104 |
Indomethacin Action Pathway |
| PathBank:SMP0000120 |
Naproxen Action Pathway |
| PathBank:SMP0000106 |
Meloxicam Action Pathway |
| PathBank:SMP0000693 |
Antrafenine Action Pathway |
| PathBank:SMP0000697 |
Flurbiprofen Action Pathway |
| PathBank:SMP0000701 |
Phenylbutazone Action Pathway |
| PathBank:SMP0000705 |
Tiaprofenic Acid Action Pathway |
| PathBank:SMP0000709 |
Salicylic Acid Action Pathway |
| PathBank:SMP0000075 |
Arachidonic Acid Metabolism |
| PathBank:SMP0000086 |
Ibuprofen Action Pathway |
| PathBank:SMP0000093 |
Diclofenac Action Pathway |
| PathBank:SMP0000098 |
Ketorolac Action Pathway |
| PathBank:SMP0000102 |
Bromfenac Action Pathway |
| PathBank:SMP0000114 |
Nabumetone Action Pathway |
| PathBank:SMP0000692 |
Antipyrine Action Pathway |
| PathBank:SMP0000696 |
Fenoprofen Action Pathway |
| PathBank:SMP0000700 |
Lornoxicam Action Pathway |
| PathBank:SMP0000704 |
Tolmetin Action Pathway |
| PathBank:SMP0000708 |
Salicylate-Sodium Action Pathway |
| PathBank:SMP0000077 |
Piroxicam Action Pathway |
| PathBank:SMP0000084 |
Etodolac Action Pathway |
| PathBank:SMP0000109 |
Mefenamic Acid Action Pathway |
| PathBank:SMP0000289 |
Diflunisal Action Pathway |
| PathBank:SMP0000116 |
Valdecoxib Action Pathway |
| PathBank:SMP0000694 |
Carprofen Action Pathway |
| PathBank:SMP0000698 |
Magnesium Salicylate Action Pathway |
| PathBank:SMP0000702 |
Nepafenac Action Pathway |
| PathBank:SMP0000706 |
Tenoxicam Action Pathway |
| PathBank:SMP0000710 |
Acetaminophen Action Pathway |
| PathBank:SMP0000353 |
Leukotriene C4 Synthesis Deficiency |
| PathBank:SMP0000085 |
Ketoprofen Action Pathway |
| PathBank:SMP0000096 |
Celecoxib Action Pathway |
| PathBank:SMP0000101 |
Suprofen Action Pathway |
| PathBank:SMP0000113 |
Oxaprozin Action Pathway |
| PathBank:SMP0000695 |
Etoricoxib Action Pathway |
| PathBank:SMP0000699 |
Lumiracoxib Action Pathway |
| PathBank:SMP0000703 |
Trisalicylate-Choline Action Pathway |
| PathBank:SMP0000707 |
Salsalate Action Pathway |